Loss of PTPN2 and PTPN1 in tumours increases the sensitivity to IFN and can enhance immune sensitivity and immune infiltration through the upregulation of tumour cell MHC class I and IFNγ-regulated chemokines3. The gene discussed is PTPN2; the disease is neoplasm.